Who owns Lantern Pharma Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of LTRN from SEC Form 13F filings across 39 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 39 institutions disclosed 2.9M shares of Lantern Pharma Inc. worth $12.0M — about 23.2% of shares outstanding; the largest disclosed holder is Empery Asset Management, LP. Source: SEC Form 13F filings, parsed by EvidInvest.
39
13F holders
$12.0M
value, 2026 filers
23.2%
of shares outstanding (2.9M sh)
13
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of LTRN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Empery Asset Management, LPNEW | 842,669 | $3.5M | 4.1% | 6.8% | new |
| 2 | CM Management, LLC | 500,000 | $2.1M | 1.4% | 4% | +100.0% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 425,118 | $1.8M | 0.0% | 3.4% | +28.0% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 291,039 | $1.2M | 0.0% | 2.3% | +150.9% |
| 5 | BIOS Capital Management, LP | 249,397 | $1.0M | 2.5% | 2% | -71.1% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 102,819 | $428,852 | 0.0% | 0.8% | -7.9% |
| 7 | VANGUARD FIDUCIARY TRUST CO | 49,950 | $208,292 | 0.0% | 0.4% | +0.7% |
| 8 | CITADEL ADVISORS LLCNEW | 47,895 | $199,722 | 0.0% | 0.4% | new |
| 9 | Westside Investment Management, Inc. | 47,850 | $199,537 | 0.0% | 0.4% | -4.4% |
| 10 | Quadrature Capital LtdNEW | 39,593 | $165,103 | 0.0% | 0.3% | new |
| 11 | NewEdge Advisors, LLCNEW | 27,049 | $112,796 | 0.0% | 0.2% | new |
| 12 | HORIZON KINETICS ASSET MANAGEMENT LLC | 25,164 | $104,934 | 0.0% | 0.2% | -4.6% |
| 13 | DAVENPORT & Co LLC | 23,814 | $99,304 | 0.0% | 0.2% | 0.0% |
| 14 | STATE STREET CORP | 23,652 | $98,629 | 0.0% | 0.2% | 0.0% |
| 15 | BlackRock, Inc. | 22,350 | $93,199 | 0.0% | 0.2% | -50.6% |
| 16 | Bank of New York Mellon Corp | 21,301 | $88,825 | 0.0% | 0.2% | 0.0% |
| 17 | NORTHERN TRUST CORP | 17,485 | $72,912 | 0.0% | 0.1% | +12.2% |
| 18 | XTX Topco LtdNEW | 17,415 | $72,621 | 0.0% | 0.1% | new |
| 19 | DIMENSIONAL FUND ADVISORS LP | 16,725 | $69,744 | 0.0% | 0.1% | -56.1% |
| 20 | UBS Group AG | 16,632 | $69,355 | 0.0% | 0.1% | +65.0% |
| 21 | Focus Partners Wealth | 15,432 | $64,351 | 0.0% | 0.1% | 0.0% |
| 22 | SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW | 14,073 | $58,684 | 0.0% | 0.1% | new |
| 23 | Cetera Investment Advisers | 12,228 | $50,991 | 0.0% | 0.1% | 0.0% |
| 24 | MARSHALL WACE, LLPNEW | 11,946 | $49,815 | 0.0% | 0.1% | new |
| 25 | Farther Finance Advisors, LLCNEW | 10,975 | $45,766 | 0.0% | 0.1% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.